For example, serum chromogranin A (CHGA) has been observed to continually rise during the progression of T1D (21) and has been proposed as a therapeutic marker to monitor the effects of verapamil treatment in T1D (22). The gene discussed is CHGA; the disease is type 1 diabetes mellitus.